Winston-Salem.

 
FREE EXCERPT

WINSTON-SALEM--Targacept's CEO and president J. Donald deBethizy stepped down after the failure of two drug candidates in clinical trials during the past year sank the company's share price. The biopharmaceutical company has created an office of the...

To continue reading

FREE SIGN UP